AstraZeneca system implemented with input from Tessella wins 2014 Bio-IT World Best Practices Award
News May 10, 2014
The Bio IT World Best Practice Award 2014 judges selected Tessella and AstraZeneca as award winners in the category for Clinical & Health IT for AstraZeneca's Real Time Analytics for Clinical Trials (REACT), receiving a honorable mention from the judges at the award ceremony.
The award was given for AstraZeneca's REACT system, implemented with input from Tessella. The system tracks vital statistics, laboratory tests and adverse events on both population and subject-specific levels during the course of a clinical trial. By collecting this information together in a platform with flexible visualization and query features, as well as a complete profile for each patient, REACT allows AstraZeneca to respond rapidly to safety concerns and swiftly identify risk factors for adverse events, protecting trial participants while rescuing trials from costly late-stage failure.
Computer scientists at Carnegie Mellon University say neural networks and supervised machine learning techniques can efficiently characterize cells that have been studied using single cell RNA-sequencing (scRNA-seq). This finding could help researchers identify new cell subtypes and differentiate between healthy and diseased cells.